Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$36,900,574
+$2,653,410 QoQ
Shares Held
287,164
+0.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#376
of 3,769 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BRADLEY FOSTER & SARGENT INC/CT holds $254,262,538 across 12 Drug Manufacturers - General names. MRK ranks #4 (14.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
333,906 | $84,802,106 | |
| 2 | ABBV |
AbbVie Inc.
|
219,509 | $55,237,244 | |
| 3 | LLY |
ELI LILLY & Co
|
35,186 | $42,203,147 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
287,164 | $36,900,574 | |
| 5 | PFE |
Pfizer Inc
|
678,377 | $16,335,318 | |
| 6 | AMGN |
Amgen Inc
|
13,889 | $5,029,484 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
38,875 | $4,911,467 | |
| 8 | NVS |
Novartis AG
|
17,635 | $2,763,757 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,900,574 | 287,164 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $34,247,164 | 284,705 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $30,418,455 | 288,984 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $24,367,816 | 290,335 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $24,063,056 | 303,980 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $28,801,021 | 320,867 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $40,511,140 | 407,229 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $47,622,294 | 419,358 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $52,453,688 | 423,697 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $56,809,884 | 430,541 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $48,182,697 | 441,962 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $47,023,853 | 456,764 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $52,705,997 | 456,764 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $59,617,764 | 560,370 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $62,532,973 | 563,614 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $48,448,097 | 562,565 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $51,234,896 | 561,971 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $45,994,194 | 560,563 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $42,995,116 | 561,001 | Shares | Sole | 2022-03-11 | |
| 2021-09-30 | $41,726,384 | 555,537 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $43,614,038 | 560,808 | Shares | Sole | 2021-08-19 | |
| 2021-03-31 | $44,323,998 | 574,964 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $48,776,581 | 596,291 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $48,218,608 | 581,297 | Shares | Sole | 2020-10-26 | |
| 2020-03-31 | $44,392,053 | 576,970 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||